AKAbraham García Kutzbach

Abraham García Kutzbach

*This is an algorithmically generated author record based on publicly available information.

Abraham García Kutzbach has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparación Clínica y Radiológica de Osteoartritis de mano erosiva vrs Osteoartritis de mano en un centro reumatológico guatemalteco

    by Emmanuel Guevara Mejia, Andrea Bran Ordoñez, Yoell David Bautista, Abraham García Kutzbach

    Introducción: Crain, en 1961, identificó presencia de inflamación en pacientes con osteoartritis de mano utilizando para ello el término de osteoartritis inflamatoria, cinco años después Peter et al. Observó alteraciones radiográficas erosivas en algunos casos de osteoartritis de mano. Objetivos: identificar la prevalencia de Osteoartritis erosiva de mano (EHOA), sus factores de riesgo y la sensibilidad de los criterios propuestos por Anandarajah. Metodología: Descriptivo de corte transversal, se comparó 400 pacientes 22 EHOA Y 378 Osteoartritis de manos (HOA) de enero 2021 a febrero 2022 recolectada por revisión de expedientes, los criterios de Anandarajah fueron utilizados. Resultados: La prevalencia de EHOA es de 5.82% por sexo varía del 4.76 al 1.06% en mujeres y hombres respectivamente, su inicio fue abrupto, el principal factor de riesgo es obesidad con diferencia estadísticamente significativa entre los grupos estudiados, otros factores son sexo femenino, hipertensión, dislipidemia, diabetes mellitus, trabajo manual y trauma articular con valores individuales mas elevados comparados con la HOA. Los criterios diagnósticos estudiados muestran una sensibilidad del 65% Conclusiones: EHOA presentó mayor componente inflamatorio, inicio abrupto de los síntomas y asociación a factores de riesgo que le predisponen a un estado proinflamatorio crónico; consideramos que la EHOA podría tener una etiopatogenia distinta que la diferencia de la HOA, empero estudios histológicos grandes serian necesarios. Palabras clave: Osteoartritis, Osteoartritis de mano, Osteoartritis de mano erosiva, incapacidad funcional, obesidad, dolor, erosiones centrales.  

  • Open Access

    Descripción clínica de pacientes con enfermedad de Still del adulto, serie de casos en un centro reumatológico guatemalteco

    by Andrea Bran Ordóñez, Juan Emmanuel Guevara Mejía, Yoell David Bautista Esquivel, Abraham García Kutzbach

    Primera descripción de casos de esta enfermedad en la región que servirá para futuras referencias. Patología autoinmune infrecuente e infra diagnosticada. Mayoría presentó todos los criterios mayores de Yamaguchi, lo que facilitó el diagnóstico. La ferritina es un marcador de inflamación y no todos la normalizaron luego de recibir tratamiento; también es apoyo para optimización de esteroides. La mayoría se adhirió bien al tratamiento y seguimiento.

  • Clinical Description of Patients with Systemic Lupus Erythematosus Evaluated in a Specialized Center for Rheumatic Diseases in Guatemala City

    by Alex López, Marvin Bustamante, Luis Kramer, Juan Pablo Araica, Yeny Maldonado, Ariel Obregón-Ponce, Abraham García Kutzbach

    Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease characterized by the production of autoantibodies generating systemic inflammation and multiorgan involvement. In this study we describe the classificatory criteria, activity index, organ damage index and treatment of patients treated at the headquarters of the Guatemalan Association Against Rheumatic Diseases (AGAR) located in Guatemala City

  • Open Access

    Descripción clínica de pacientes con Lupus Eritematoso Sistémico evaluados en un Centro Especializado en Enfermedades Reumáticas de la Ciudad de Guatemala (AGAR)

    by Alex López, Marvin Bustamante, Luis Kramer, Juan Pablo Araica, Yeny Maldonado, Ariel Obregón-Ponce, Abraham García Kutzbach

    LES es una enfermedad autoinmune inflamatoria crónica, caracterizada por el incremento de autoanticuerpos que genera inflamación sistémica y afectación multiorgánica. En la etiopatogenia intervienen factores genéticos, hormonales, y ambientales, y se presenta como un conjunto de manifestaciones clínicas muy variables, por lo que su diagnóstico es un reto para el médico tratante. Esta enfermedad es de dominancia mundial y se presenta en todos los grupos étnicos, con una mayor prevalencia en los afroamericanos. Según The Lupus Foundation of America, 1,5 millones de estadounidenses y al menos 5 millones de personas en todo el mundo tienen alguna forma de lupus.

  • Reactive arthritis: update 2018

    by A. García-Kutzbach, J. Chacón-Súchite, H. García-Ferrer, I. Iraheta

    At this time, reactive arthritis (ReA) is considered to be part of the spectrum of the spondyloarthritis, previously known as Reiter’s syndrome, and refers to an infection induced systemic illness, characterized by a sterile synovitis occurring in a genetically predisposed individual, secondary to an infection localized in a distant organ/system, but also accompanied with multiple extra articular manifestations.


  • Open Access

    Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab

    by Nathan Vastesaeger, Abraham Garcia Kutzbach, Howard Amital, Karel Pavelka, María Alicia Lazaro, Robert J. Moots, Jürgen Wollenhaupt, Cristiano A. F. Zerbini, Ingrid Louw, Bernard Combe, et al.

    Objective. To create a tool to predict probability of remission and low disease activity (LDA) in patients with RA being considered for anti-TNF treatment in clinical practice. Methods. We analysed data from GO-MORE, an open-label, multinational, prospective study in biologic-naïve patients with active RA (DAS28-ESR ⩾3.2) despite DMARD therapy. Patients received 50 mg s.c. golimumab (GLM) once monthly for 6 months. In secondary analyses, regression models were used to determine the best set of baseline factors to predict remission (DAS28-ESR Results. In 3280 efficacy-evaluable patients, of 12 factors included in initial regression models predicting remission or LDA, six were retained in final multivariable models. Greater likelihood of LDA and remission was associated with being male; younger age; lower HAQ, ESR (or CRP) and tender joint count (or swollen joint count) scores; and absence of comorbidities. In models predicting 1-, 3- and 6-month LDA or remission, area under the receiver operating curve was 0.648–0.809 (R2 = 0.0397–0.1078). The models also predicted 6-month HAQ and EuroQoL-5-dimension scores. A series of matrices were developed to easily show predicted rates of remission and LDA. Conclusion. A matrix tool was developed to show predicted GLM treatment outcomes in patients with RA, based on a combination of six baseline characteristics. The tool could help provide practical guidance in selection of candidates for anti-TNF therapy.


  • Prevalence of Musculoskeletal Diseases in Guatemala, Central America

    by Ariel Obregón-Ponce, Isa Iraheta, Helga García-Ferrer, Bayardo Mejia, Abraham García-Kutzbach

    Background Guatemala is a multiethnic, multilingual, and multicultural country. We have evaluated 2 different ethnic groups from (1) San Juan Sacatepéquez County (SJSC), a rural population (30% illiterate), with 65% from Kaqchiquel ethnic group; and (2) Zone 5 of Guatemala City (Z5GC), an urban population (6.6% illiterate), with 95.5% mestizos. Objective This study aimed to measure simultaneously the prevalence of rheumatic diseases in these 2 Guatemalan populations, both located in the State of Guatemala. Methods A convenience sample of 4000 inhabitants 15 years and older was selected in each group. The Core Community Oriented Program for Control of Rheumatic Diseases Questionnaire was used in this survey. Phase 1 was for screening (identification of study subjects), phase 2 was for obtaining information from subjects with musculoskeletal complaints, and phase 3 was for rheumatologic diagnostic purposes. Phases 1 and 2 were performed by 6 interviewers. Phase 3 was completed by 4 rheumatologists. Results In phase I, 8000 subjects were identified in both groups. In phase II, 949 subjects reported musculoskeletal complaints: 371 (39%) in Z5GC and 578 (61%) in SJSC. In phase III, 419 patients were clinically evaluated: 141 (34%) in Z5GC and 278 (66%) in SJSC. The most prevalent musculoskeletal diseases were (1) osteoarthritis, (2) soft tissue rheumatism, (3) rheumatoid arthritis, (4) low back pain, and (5) arthralgias of unknown etiology. Osteoarthritis and soft tissue rheumatism were significantly more common in the rural population. Conclusions The most prevalent musculoskeletal diseases in Guatemala seem to be similar to those in most previous Community Oriented Program for Control of Rheumatic Diseases studies. Most subjects were still working. Further studies examining medical care received and impact on function can now be of interest.